First Time in Human Study

NCT01031186 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder and Anxiety Disorders

Interventions

DRUG: GSK356278
DRUG: PLACEBO

Sponsor

GlaxoSmithKline